A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CLOROX CO /DE/
CLX
$11.9B
Mkt Cap
$95.55
+1.87%
CLOROX CO /DE/ (CLX) has a current P/E ratio of 15.6, compared to its historical median P/E of 20.9. The stock is currently considered Fair based on its historical valuation range.
CLOROX CO /DE/ (CLX) has a 5-year average return on invested capital (ROIC) of 20.5%. This indicates strong capital allocation and a potential competitive advantage.
CLOROX CO /DE/ (CLX) has a market capitalization of $11.6B. It is classified as a large-cap stock.
Yes, CLOROX CO /DE/ (CLX) pays a dividend with a trailing twelve-month yield of 5.21%. The company also returns capital through share buybacks, with a buyback yield of 2.86%.
Based on historical P/E analysis, CLOROX CO /DE/ (CLX) appears fair. The current P/E of 15.6 is 25% below its historical median of 20.9. The estimated fair value CAGR (P/E method) is -17.0%.
CLOROX CO /DE/ (CLX) operates in the Specialty Cleaning, Polishing And Sanitation Preparations industry, within the Consumer Defensive sector.
CLOROX CO /DE/ (CLX) reported annual revenue of $7.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Clorox is a multinational manufacturer and marketer of consumer and professional products with approximately 7,600 employees and operations in roughly 25 countries, selling into approximately 100 markets. The company generates revenue through four reportable segments—Health and Wellness (cleaning, disinfecting, and professional products), Household (bags, wraps, cat litter, and grilling products), Lifestyle (food, water-filtration, and natural personal care), and International—with over 80% of sales from brands holding No. 1 or No. 2 market share positions in their categories. Distribution occurs primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, and e-commerce channels, with Walmart and affiliates representing 27% of consolidated net sales. The company's business model relies on brand equity and consumer trust in iconic names such as Clorox bleach, Glad bags, Fresh Step cat litter, Hidden Valley dressings, Brita water filters, and Burt's Bees personal care products, supported by substantial advertising and promotional investments. Clorox's competitive moat derives from strong brand recognition, market-leading positions across diverse consumer categories, and a streamlined operating model enhanced by digital transformation initiatives including a modernized enterprise resource planning system and cloud-based infrastructure designed to improve supply chain efficiency and innovation velocity.
【Digital transformation and innovation acceleration】 Management expects continued progress from its modernized ERP foundation and digital capabilities to drive operational efficiencies and enable faster innovation execution in the second half of fiscal 2026 and beyond. The company anticipates that its substantial innovation pipeline—including new product launches and platform expansions across cleaning, litter, and other categories—will deliver superior consumer value and support market share recovery, though execution has proven more challenging than initially expected in certain categories such as cat litter. Management remains focused on leveraging its Net Revenue Management capabilities and targeted promotional strategies to navigate a consumer environment characterized by value-seeking behavior and heightened competitive activity, while managing cost pressures from inflation, tariffs, and supply chain dynamics. The company expects to realize cost savings and operational leverage from its transformation investments and supply chain optimization, though timing of certain benefits has shifted into fiscal 2027, and management is approaching pricing actions with discipline given consumer stress.
| Metric | Target | Period |
|---|---|---|
| Transformational investment | $570 to $580 million | Five-year period beginning fiscal 2022 |
| Tariff cost impact | Around $40 million | Fiscal 2026 |
| GOJO revenue contribution | $200 million in Q4 and approximately $300 million for full fiscal year 2027 | Q4 FY2026 and FY2027 |
| GOJO cost synergies | Approximately $110 million above the $100 million run rate | Fiscal 2027 |
| ERP-related sales normalization benefit | $0.90 in EPS and approximately 3.5 points on sales | Fiscal 2027 |
Transformational investment (Five-year period beginning fiscal 2022): “The total incremental transformational investment is expected to be $570 to $580 million.”
Tariff cost impact (Fiscal 2026): “Yes, we expect higher costs from tariff to be around $40 million.”
GOJO revenue contribution (Q4 FY2026 and FY2027): “That means that we will be adding $200 million in Q4, right? Which adds about 10%, you know, for the quarter and about 3% for the full year. We'll add the remainder in fiscal year 2027.”
GOJO cost synergies (Fiscal 2027): “Next year we expect about $110 million above and beyond the $100 million run rate.”
ERP-related sales normalization benefit (Fiscal 2027): “So next year, when you have, you know, normalized, you know, shipment and sales, you would have a pickup of, you know, about 3.5 point on sales and a pickup of about $0.90 in EPS.”
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K, Q4 FY2026 Earnings Call, Q3 FY2026 Earnings Call, Q2 FY2026 Earnings Call, Q1 FY2026 Earnings Call
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.8B | 7.1B | 7.1B | 7.4B | 7.1B | 7.3B |
| Net Income | 756M | 810M | 280M | 149M | 462M | 710M |
| EPS | $6.21 | $6.52 | $2.25 | $1.20 | $3.73 | $5.58 |
| Free Cash Flow | 380M | 761M | 483M | 930M | 535M | 945M |
| ROIC | 0.0% | 33.5% | 14.0% | 7.8% | 19.3% | 27.8% |
| Gross Margin | 43.8% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% |
| Debt/Equity | 0.00 | 7.75 | 7.58 | 11.49 | 4.88 | 6.77 |
| Dividends/Share | $4.98 | $4.88 | $4.80 | $4.72 | $3.48 | $4.49 |
| Operating Income | 0 | 1.2B | 476M | 316M | 704M | 990M |
| Operating Margin | 0.0% | 16.2% | 6.7% | 4.3% | 9.9% | 13.5% |
| ROE | 0.0% | 249.6% | 102.2% | 38.4% | 95.6% | 107.7% |
| Shares Outstanding | 121M | 124M | 124M | 124M | 124M | 127M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 5.5B | 5.7B | 5.8B | 6.0B | 6.1B | 6.2B | 6.7B | 7.3B | 7.1B | 7.4B | 7.1B | 7.1B | 6.8B |
| Gross Margin | 42.7% | 43.6% | 45.1% | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% | 43.8% |
| R&D | 125M | 136M | 141M | 135M | 132M | 136M | 145M | 149M | 132M | 138M | 126M | 121M | 116M |
| SG&A | 751M | 798M | 806M | 810M | 837M | 856M | 969M | 1.0B | 954M | 1.2B | 1.2B | 1.1B | 1.1B |
| EBIT | 966M | 995M | 1.1B | 1.1B | 1.1B | 1.1B | 1.3B | 990M | 704M | 316M | 476M | 1.2B | 0 |
| Op. Margin | 17.5% | 17.6% | 18.6% | 18.7% | 18.6% | 18.0% | 19.1% | 13.5% | 9.9% | 4.3% | 6.7% | 16.2% | 0.0% |
| Net Income | 558M | 580M | 648M | 701M | 823M | 820M | 939M | 710M | 462M | 149M | 280M | 810M | 756M |
| Net Margin | 10.1% | 10.3% | 11.2% | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% | 11.2% |
| Non-Recurring | 3.0M | 18M | 21M | 34M | 1.0M | 0 | 0 | 228M | 0 | 377M | 29M | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 29.2% | 37.7% | 36.9% | 33.6% | 30.2% | 28.9% | 34.2% | 27.8% | 19.3% | 7.8% | 14.0% | 33.5% | 0.0% |
| ROE | 372.0% | 426.5% | 312.3% | 167.1% | 113.4% | 127.6% | 128.0% | 107.7% | 95.6% | 38.4% | 102.2% | 249.6% | 0.0% |
| ROA | 13.0% | 13.8% | 15.0% | 15.4% | 16.3% | 16.1% | 16.6% | 11.3% | 7.4% | 2.5% | 4.8% | 14.3% | 11.7% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 767M | 874M | 778M | 865M | 976M | 992M | 1.5B | 1.3B | 786M | 1.2B | 695M | 981M | 576M |
| Free Cash Flow | 630M | 749M | 606M | 634M | 782M | 786M | 1.3B | 945M | 535M | 930M | 483M | 761M | 380M |
| Owner Earnings | 554M | 673M | 568M | 651M | 757M | 769M | 1.3B | 1.0B | 510M | 849M | 386M | 681M | 284M |
| CapEx | 137M | 125M | 172M | 231M | 194M | 206M | 254M | 331M | 251M | 228M | 212M | 220M | 196M |
| Maint. CapEx | 177M | 169M | 165M | 163M | 166M | 180M | 180M | 211M | 224M | 236M | 235M | 219M | 226M |
| Growth CapEx | 0 | 0 | 7.0M | 68M | 28M | 26M | 74M | 120M | 27M | 0 | 0 | 1.0M | 0 |
| D&A | 177M | 169M | 165M | 163M | 166M | 180M | 180M | 211M | 224M | 236M | 235M | 219M | 226M |
| CapEx/OCF | 17.9% | 14.3% | 22.1% | 26.6% | 19.9% | 20.8% | 16.4% | 25.9% | 31.9% | 19.7% | 30.5% | 22.4% | 34.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 368M | 385M | 398M | 412M | 450M | 490M | 533M | 558M | 571M | 583M | 595M | 602M | 602M |
| Dividend Yield | 4.5% | 3.9% | 3.3% | 3.2% | 3.3% | 3.1% | 3.0% | 2.6% | 3.3% | 3.5% | 3.6% | 3.4% | 5.2% |
| Share Buybacks | 260M | 434M | 254M | 183M | 271M | 661M | 248M | 905M | 25M | 0 | 0 | 332M | 331M |
| Buyback Yield | 3.0% | 4.2% | 1.9% | 1.3% | 1.9% | 4.1% | 1.1% | 4.6% | 0.2% | N/A | N/A | 2.3% | 2.9% |
| Stock-Based Comp | 36M | 32M | 45M | 51M | 53M | 43M | 50M | 50M | 52M | 73M | 74M | 81M | 66M |
| Debt Repayment | 0 | 575M | 300M | 0 | 400M | 0 | 0 | 0 | 1.4B | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 2.0B | 1.8B | 1.9B | 1.8B | 2.2B | 2.6B | 1.9B | 2.5B | 2.5B | 2.2B | 2.3B | 2.3B | 2.9B |
| Cash & Equiv. | 329M | 382M | 401M | 418M | 131M | 111M | 871M | 319M | 183M | 367M | 202M | 167M | 1.2B |
| Long-Term Debt | 1.6B | 1.8B | 1.8B | 1.4B | 2.3B | 2.3B | 2.8B | 2.5B | 2.5B | 2.5B | 2.5B | 2.5B | 2.5B |
| Debt/Equity | 14.97 | 18.48 | 7.78 | 4.05 | 3.42 | 4.80 | 3.06 | 6.77 | 4.88 | 11.49 | 7.58 | 7.75 | 0.00 |
| Interest Coverage | 9.4 | 9.9 | 12.2 | 12.7 | 13.4 | 11.6 | 13.0 | 10.0 | 6.6 | 3.5 | 5.3 | 13.1 | 13.1 |
| Equity | 154M | 118M | 297M | 542M | 726M | 559M | 908M | 411M | 556M | 220M | 328M | 321M | -67M |
| Total Assets | 4.3B | 4.2B | 4.5B | 4.6B | 5.1B | 5.1B | 6.2B | 6.3B | 6.2B | 5.9B | 5.8B | 5.6B | 6.4B |
| Total Liabilities | 4.1B | 4.0B | 4.2B | 4.0B | 4.3B | 4.6B | 5.3B | 5.7B | 5.4B | 5.6B | 5.3B | 5.1B | 6.3B |
| Intangibles | 611M | 585M | 735M | 722M | 134M | 912M | 894M | 918M | 884M | 712M | 681M | 566M | 49M |
| Retained Earnings | 1.7B | 1.9B | 2.2B | 2.4B | 2.8B | 3.1B | 3.6B | 1.0B | 1.0B | 583M | 250M | 432M | 223M |
| Working Capital | -243M | 24M | -73M | -295M | 111M | -135M | 602M | -227M | -59M | -89M | 48M | -311M | -504M |
| Current Assets | 1.4B | 1.4B | 1.5B | 1.5B | 1.3B | 1.3B | 2.0B | 1.8B | 1.7B | 1.8B | 1.6B | 1.6B | 2.7B |
| Current Liabilities | 1.6B | 1.4B | 1.6B | 1.8B | 1.2B | 1.4B | 1.4B | 2.1B | 1.8B | 1.9B | 1.6B | 1.9B | 3.2B |
| Per Share Data | |||||||||||||
| EPS | 4.23 | 4.37 | 4.92 | 5.33 | 6.26 | 6.32 | 7.36 | 5.58 | 3.73 | 1.20 | 2.25 | 6.52 | 6.21 |
| Owner EPS | 4.20 | 5.07 | 4.31 | 4.95 | 5.76 | 5.93 | 10.31 | 7.98 | 4.12 | 6.84 | 3.10 | 5.48 | 2.35 |
| Book Value | 1.17 | 0.89 | 2.26 | 4.12 | 5.52 | 4.31 | 7.12 | 3.23 | 4.49 | 1.77 | 2.64 | 2.58 | -0.55 |
| Cash Flow/Share | 5.81 | 6.59 | 5.91 | 6.58 | 7.42 | 7.65 | 12.12 | 10.03 | 6.35 | 9.33 | 5.58 | 7.90 | 8.12 |
| Dividends/Share | 2.87 | 2.99 | 3.11 | 3.24 | 3.60 | 3.94 | 4.29 | 4.49 | 3.48 | 4.72 | 4.80 | 4.88 | 4.98 |
| Shares Out. | 131.9M | 132.7M | 131.7M | 131.5M | 131.5M | 129.7M | 127.6M | 127.2M | 123.9M | 124.2M | 124.4M | 124.2M | 120.9M |
| Valuation | |||||||||||||
| P/E Ratio | 15.5 | 18.0 | 20.9 | 19.7 | 17.0 | 19.7 | 24.5 | 27.5 | 32.2 | 118.6 | 56.9 | 17.7 | 15.4 |
| P/FCF | 13.7 | 13.9 | 22.4 | 21.8 | 17.9 | 20.6 | 17.8 | 20.6 | 27.8 | 19.0 | 33.0 | 18.8 | 30.4 |
| EV/EBIT | 10.8 | 12.2 | 14.1 | 13.6 | 14.2 | 16.6 | 18.7 | 21.9 | 24.5 | 61.6 | 37.8 | 14.3 | N/A |
| Price/Book | N/A | N/A | 45.7 | 25.5 | 19.2 | 29.0 | 25.3 | 47.5 | 26.8 | 80.3 | 48.6 | 44.7 | N/A |
| Price/Sales | 1.5 | 1.7 | 2.1 | 2.2 | 2.2 | 2.5 | 2.6 | 3.0 | 2.4 | 2.2 | 2.3 | 2.5 | 1.7 |
| FCF Yield | 7.3% | 7.2% | 4.5% | 4.6% | 5.6% | 4.9% | 5.6% | 4.8% | 3.6% | 5.3% | 3.0% | 5.3% | 3.3% |
| Market Cap | 8.6B | 10.4B | 13.6B | 13.8B | 14.0B | 16.2B | 23.0B | 19.5B | 14.9B | 17.7B | 15.9B | 14.3B | 11.6B |
| Avg. Price | 61.87 | 73.73 | 91.72 | 98.15 | 103.49 | 121.93 | 138.72 | 170.42 | 137.99 | 133.36 | 132.44 | 142.75 | 95.55 |
| Year-End Price | 65.42 | 78.69 | 102.97 | 105.25 | 106.29 | 124.78 | 180.03 | 153.28 | 120.23 | 142.28 | 128.00 | 115.44 | 95.55 |
CLOROX CO /DE/ passes 5 of 9 quality checks, suggesting mixed fundamentals.
CLOROX CO /DE/ trades at 15.6x trailing earnings, compared to its 15-year median P/E of 20.9x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 14.8x vs a median of 20.6x. The company's 5-year average ROIC is 20.5% with a gross margin of 41.4%. Total shareholder yield (dividends + buybacks) is 8.1%. At current prices, the estimated annualized return to fair value is -5.1%.
CLOROX CO /DE/ (CLX) has a net profit margin of 11.4%. This is a healthy margin.
CLOROX CO /DE/ (CLX) generated $761 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CLOROX CO /DE/ (CLX) has a debt-to-equity ratio of 7.75. This indicates higher leverage, which may increase financial risk.
CLOROX CO /DE/ (CLX) reported earnings per share (EPS) of $6.52 in its most recent fiscal year.
CLOROX CO /DE/ (CLX) has a return on equity (ROE) of 249.6%. This indicates the company generates strong returns for shareholders.
CLOROX CO /DE/ (CLX) has a 5-year average gross margin of 41.4%. This indicates decent pricing power.
The Ledger Terminal provides 18 years of financial data for CLOROX CO /DE/ (CLX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CLOROX CO /DE/ (CLX) has a book value per share of $2.58, based on its most recent annual SEC filing.
Based on recent SEC filings and earnings disclosures, Management expects continued progress from its modernized ERP foundation and digital capabilities to drive operational efficiencies and enable faster innovation execution in the second half of fiscal 2026 and beyond. The company anticipates that its substantial innovation pipeline—including new product launches and platform expansions across cleaning, litter, and other categories—will deliver superior consumer value and support market share recovery, though execution has proven more challenging than initially expected in certain categories such as cat litter. Management remains focused on leveraging its Net Revenue Management capabilities and targeted promotional strategies to navigate a consumer environment characterized by value-seeking behavior and heightened competitive activity, while managing cost pressures from inflation, tariffs, and supply chain dynamics. The company expects to realize cost savings and operational leverage from its transformation investments and supply chain optimization, though timing of certain benefits has shifted into fiscal 2027, and management is approaching pricing actions with discipline given consumer stress.
Based on recent SEC filings and earnings calls, CLOROX CO /DE/ (CLX) has provided the following forward guidance: Transformational investment: $570 to $580 million (Five-year period beginning fiscal 2022); Tariff cost impact: Around $40 million (Fiscal 2026); GOJO revenue contribution: $200 million in Q4 and approximately $300 million for full fiscal year 2027 (Q4 FY2026 and FY2027); GOJO cost synergies: Approximately $110 million above the $100 million run rate (Fiscal 2027); ERP-related sales normalization benefit: $0.90 in EPS and approximately 3.5 points on sales (Fiscal 2027).
No recent press releases.